Growth Stocks: My Love and Hate Relationship With Them

Are growth stocks for you? I’ll share some of my experiences with growth stocks and my love and hate relationship with them.

| More on:

If you don’t know by now, some pundits have been saying for weeks that there has been a rotation out of growth stocks and into value stocks, as interest rates are expected to rise. While I remember some pundits saying last year that growth stocks have outperformed value stocks for 10 years, which was why investors should have growth stocks in their portfolios.

I know how thrilling it can be to buy growth stocks, and they turn out to work beautifully in your favour by appreciating quickly. Every time that happens, it’s not that I’m smart, but just that the market was on my side at the time.

I still hold a number of growth stocks. And obviously, that has hurt my portfolio recently. Below, I’ll share some of my experiences with growth stocks and my love and hate relationship with them.

This little tech stock is a Canadian Dividend Aristocrat

In hindsight, anyone can tell you that last year was a great time to take profit in growth stocks. Personally, I always keep an eye on my holdings, especially the ones that aren’t core dividend holdings.

One little tech stock that was interestingly also a Canadian Dividend Aristocrat caught my attention. Thinking that it was attractively priced, I bought shares in Tecsys (TSX:TCS) in April and May 2021 after it based and seemed to experience support from its 50-day simple moving average. Within five months, I booked total returns of approximately 31% in the tech stock.

My buy rationale was that it was fundamentally sound and had a track record of increasing its dividend. This was when using technical analysis as an assisting tool makes sense. My rationale to sell was that it was getting close to its fair price at the time and that it was getting exhausted technically.

The tech stock is a good buy for long-term growth now that it has pulled back. The problem for me is that I started buying when it retreated to similar levels that I last bought. And my position is now in the red by about 18%. But now I’m being short-sighted again, as it’s probably a good time to average down if I have excess cash.

One analyst named the growth stock as one of his top picks in December 2021 on BNN when the stock was 31% higher:

“One of the top 30 stocks on the TSX for the past three years. They develop and maintain supply chain management software, so they are right in the sweet spot now. Main clients health care providers in the US and companies with complex distribution. They just reported record results and backlog. This will be a $100 stock in the future. Yield 0.6%.”

Stephen Takacsy, the Chief Investment Officer and Portfolio Manager at Lester Asset Management

Taking profits at the wrong time

Other times, I have taken profit too soon in growth stocks. For example, I have sold a stock after it appreciated meaningfully by 20-30% only to see that stock triple from my position.

Another time, I built a meaningful position in a growth stock and saw it quadruple but only ended up with a tiny profit after it came crashing down. It now trades at about 15% below my selling level. I have since learned that some investors utilize the strategy of getting their money back after a holding has doubled and let the house money run. In the case of a quadruple, it would make good sense to even take back half of the position at a high.

At the end of the day, we really don’t know if growth stocks are going to go up or down. Their trajectory depends on macro factors and if the businesses can sustain a high growth rate. Very few are like Amazon that can grow for decades at a high rate. Even so, AMZN stock has still fallen hard at times during the Internet Bubble and other market crashes.

Investors should tread carefully, especially with higher-risk, high-growth stocks. Pick your holdings prudently and even throw in some quality value and dividend stocks for diversification.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. The Motley Fool owns and recommends Tecsys Inc. The Motley Fool recommends Amazon. Fool contributor Kay Ng owns shares of Amazon and Tecsys.

More on Tech Stocks

Man data analyze
Tech Stocks

3 Reasons Celestica Stock Is a Screaming Buy Now

These three reasons make Celestica stock a screaming buy for long-term investors.

Read more »

profit rises over time
Dividend Stocks

These 2 Dow Stocks Are Set to Soar in 2025 and Beyond

Two Dow Jones stocks are screaming buys but Canadians must hold them in an RRSP or RRIF to avoid paying…

Read more »

telehealth stocks
Tech Stocks

Well Health Stock: Buy, Sell, or Hold?

Another record-breaking quarter and strong demand sets the stage for continued momentum for Well Health stock.

Read more »

3 colorful arrows racing straight up on a black background.
Dividend Stocks

TSX Stocks Soaring Higher With No Signs of Slowing

Three TSX stocks continue to beat the market and could soar higher in an improving investment landscape.

Read more »

profit rises over time
Tech Stocks

2 Non-AI Tech Stocks to Buy in November for Better Returns

Not all AI stocks are riding the hype train, and for many investors, well-understood and predictable growth stocks might be…

Read more »

worry concern
Tech Stocks

In a Few Years, You’ll Probably Regret Not Owning BlackBerry Stock

Here’s why I believe BlackBerry could be one of the most overlooked Canadian tech stocks right now.

Read more »

A worker uses a double monitor computer screen in an office.
Tech Stocks

Is Constellation Software Stock a Buy for its 0.25% Dividend Yield?

Here's what investors may want to consider when it comes to Dollarama (TSX:DOL) and its relatively low dividend yield.

Read more »

Nurse talks with a teenager about medication
Tech Stocks

Shares of WELL Health Just Zoomed. Is It a Buy?

Given its improving financials and healthy growth prospects, WELL Health could deliver superior returns over the next three years.

Read more »